DILH
PBYI icon

Dai-ichi Life Holdings’s Puma Biotechnology PBYI Stock Holding History

Dai-ichi Life Holdings’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-42,667
Closed -$2.86M – 339
2016
Q3 		$2.86M Buy
42,667
+14,096
+49% +$713K 0.09% 243
2016
Q2 		$851K Buy
+28,571
New +$893K 0.03% 406
2015
Q3 		– Sell
-671
Closed -$78K – 607
2015
Q2 		$78K Buy
+671
New +$122K ﹤0.01% 654

Other funds holding PBYI

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Dai-ichi Life Holdings's PBYI Position: Q4 2016 in Review

Dai-ichi Life Holdings sold out of Puma Biotechnology (PBYI) in Q4 2016, closing a stake of 42,667 shares — an estimated $2.86M sold.

Dai-ichi Life Holdings first reported a position in PBYI in Q2 2015 and held it in 3 quarters. The position peaked at $2.86M in Q3 2016. 128 funds tracked by Wall St. Rank hold PBYI as of Q4 2016.

  • Dai-ichi Life Holdings reported no remaining Puma Biotechnology position as of Q4 2016 after selling out during the quarter.
  • Dai-ichi Life Holdings sold 42,667 Puma Biotechnology shares in Q4 2016, an estimated $2.86M.
  • Dai-ichi Life Holdings first reported a position in Puma Biotechnology in Q2 2015 and held it in 3 quarters.
  • Dai-ichi Life Holdings's Puma Biotechnology position peaked at $2.86M in Q3 2016.
  • 128 funds tracked by Wall St. Rank held Puma Biotechnology as of Q4 2016.

Based on Dai-ichi Life Holdings's 13F filing for Q4 2016, filed 14 Feb 2017.